These results are consistent with a model in which CSF1 secretion by glioma cells recruits CSF1R-expressing microglia or macrophages to the tumor microenvironment, as demonstrated previously in murine models [51, 52], and may point to a patient population that would be particularly susceptible to CSF1R blockade. The gene discussed is CSF1; the disease is neoplasm.